```html

Jameson Sign (Hyperpigmentation)

What is Jameson Sign (Hyperpigmentation)?

Jameson sign is a classic dermatologic finding characterized by diffuse, symmetric hyperpigmentation of the skin, most often observed on the upper chest, neck, and facial areas. The term is named after Dr. A. A. Jameson, who first described the pattern in patients with chronic adrenal insufficiency. In modern practice, the sign is frequently used as a visual clue for underlying endocrine or systemic disorders that increase melanocyte‑stimulating activity, such as excess adrenocorticotropic hormone (ACTH) or elevated melanocyte‑stimulating hormone (MSH). The hyperpigmentation appears as a slate‑gray or bronze‑brown discoloration that may be more pronounced after sun exposure.

While the sign itself is benign, it often signals a deeper health problem that requires evaluation. Recognizing Jameson sign early can lead to prompt diagnosis of serious conditions like Addison’s disease, hemochromatosis, or certain cancers.

Common Causes

The following conditions are most frequently associated with Jameson sign or a similar pattern of generalized hyperpigmentation:

• Addison’s disease (primary adrenal insufficiency) – low cortisol leads to compensatory ACTH production, which cross‑reacts with melanocortin‑1 receptors.
• Secondary adrenal insufficiency – severe chronic ACTH deficiency may still cause intermittent hyperpigmentation during stress.
• Hemochromatosis – iron overload stimulates melanin production and causes a bronze skin tone.
• Chronic kidney disease – uremic toxins and altered hormone metabolism can darken the skin.
• Melanoma or other metastatic cancers – paraneoplastic secretion of ACTH‑like peptides.
• Chronic infections such as tuberculosis or HIV – inflammation and cytokine release can affect melanocyte activity.
• Polycystic ovary syndrome (PCOS) – hyperinsulinemia may increase androgen‑derived melanin synthesis.
• Medications – especially oral contraceptives, antimalarials (chloroquine), and some chemotherapeutic agents that stimulate melanogenesis.
• Genetic disorders – e.g., familial hyperpigmentation syndromes (e.g., Peutz‑Jeghers).
• Chronic stress or Cushing‑like syndromes – prolonged high ACTH levels.

Associated Symptoms

Jameson sign rarely appears in isolation. Look for these accompanying features, which can help pinpoint the underlying cause:

• Fatigue, weakness, and weight loss (common in adrenal insufficiency).
• Salt craving and low blood pressure, especially orthostatic hypotension.
• Abdominal pain, nausea, or vomiting.
• Hyperkalemia (elevated potassium) and hyponatremia (low sodium) in adrenal disorders.
• Joint pain or arthralgias (seen with hemochromatosis).
• Dark urine or bronze‑colored blood (suggestive of iron overload).
• Irregular menstrual cycles, hirsutism, or infertility (PCOS).
• Persistent cough, night sweats, or fever (tuberculosis).
• Changes in urine output or swelling in the legs (chronic kidney disease).
• Unexplained weight gain, facial rounding, or “buffalo hump” (Cushing‑like states).

When to See a Doctor

Because Jameson sign often heralds systemic disease, you should seek medical attention promptly if you notice any of the following:

• Rapidly spreading or darkening of the pigmentation.
• Associated symptoms such as severe fatigue, dizziness, or fainting.
• Persistent abdominal pain, vomiting, or unexplained weight loss.
• Signs of electrolyte imbalance (muscle cramps, irregular heartbeat).
• New onset of joint pain, bronze-colored urine, or liver enlargement.
• If you are pregnant, breastfeeding, or taking new medications and notice skin darkening.

Early evaluation can prevent complications like adrenal crisis, organ damage from iron overload, or delayed cancer diagnosis.

Diagnosis

Evaluation of Jameson sign involves a stepwise approach that combines a thorough history, physical exam, and targeted laboratory testing.

1. Clinical History & Physical Examination

• Document onset, progression, and distribution of pigmentation.
• Review medication list, occupational exposures, and family history of endocrine or metabolic disease.
• Check vital signs (especially orthostatic blood pressure) and look for signs of chronic disease (e.g., hepatomegaly, splenomegaly).

2. Laboratory Tests

• Morning serum cortisol and ACTH – low cortisol with high ACTH confirms primary adrenal insufficiency.<sup>1</sup>
• Basic metabolic panel – assesses sodium, potassium, glucose, and renal function.
• Serum ferritin, transferrin saturation, and total iron‑binding capacity – screen for hemochromatosis.<sup>2</sup>
• Liver function tests – elevated transaminases may indicate iron overload or chronic infection.
• Autoimmune panels (21‑hydroxylase antibodies) – help differentiate autoimmune Addison’s.
• Renal function tests (creatinine, BUN) for chronic kidney disease.
• Hormone panel for PCOS (LH/FSH ratio, testosterone).

3. Imaging Studies

• CT or MRI of the adrenal glands – evaluates atrophy, hemorrhage, or infiltrative disease.
• Abdominal ultrasound – useful for detecting liver iron deposition in hemochromatosis.
• Chest X‑ray or CT if a paraneoplastic cause is suspected.

4. Skin Biopsy (rarely needed)

A punch biopsy can confirm increased melanin in basal keratinocytes and rule out pigmentary disorders such as melasma or post‑inflammatory hyperpigmentation.

Treatment Options

Treatment is directed at the underlying cause; the hyperpigmentation often improves once the primary disease is controlled.

1. Hormonal Replacement

• Addison’s disease: Hydrocortisone (10‑30 mg daily) and fludrocortisone (0.05‑0.2 mg daily) to replace cortisol and mineralocorticoid activity. Dose adjustments are required during stress or illness.<sup>3</sup>
• Secondary adrenal insufficiency: Physiologic glucocorticoid replacement without mineralocorticoids.

2. Iron‑Reduction Therapy

• Phlebotomy is the first‑line treatment for hereditary hemochromatosis (500 mL weekly until ferritin <50 ng/mL).<sup>2</sup>
• Iron chelators (deferasirox, deferoxamine) for patients who cannot undergo phlebotomy.

3. Management of Chronic Kidney Disease

• ACE inhibitors or ARBs to control blood pressure and proteinuria.
• Dialysis or renal transplantation when indicated.

4. Treatment of Underlying Infections or Malignancy

• Appropriate antimicrobial therapy for TB or HIV.
• Oncologic treatment (surgery, chemotherapy, immunotherapy) for ACTH‑producing tumors.

5. Symptomatic Skin Care

• Topical depigmenting agents – hydroquinone 4 % or azelaic acid 20 % for cosmetic improvement.
• Sunscreen (SPF 30 + , broad‑spectrum) to prevent further darkening.
• Gentle skin cleansers; avoid abrasive scrubs that can trigger post‑inflammatory hyperpigmentation.

6. Lifestyle Adjustments

• Balanced diet low in iron for hemochromatosis (avoid raw shellfish, fortified cereals).
• Stress‑reduction techniques (mindfulness, yoga) to lower endogenous ACTH surges.
• Regular monitoring of hormone levels and electrolytes as advised by your endocrinologist.

Prevention Tips

While not all causes are preventable, many risk factors can be mitigated:

• Vaccination and infection control – Stay up to date on TB screening and HIV prevention.
• Healthy iron intake – Avoid excess supplements unless prescribed; limit red meat and alcohol in at‑risk individuals.
• Medication review – Discuss with your provider any drugs that might cause hyperpigmentation.
• Regular health checks – Annual blood work for cortisol, electrolytes, and ferritin if you have a family history of adrenal or iron disorders.
• Sun protection – Daily sunscreen reduces UV‑induced melanin production and helps keep existing pigmentation from darkening.
• Stress management – Chronic stress can elevate ACTH; techniques such as meditation or counseling are beneficial.

Emergency Warning Signs

References

1. Mayo Clinic. “Addison’s disease.” Updated 2023. https://www.mayoclinic.org
2. National Institute of Diabetes and Digestive and Kidney Diseases. “Hemochromatosis.” 2022. https://www.niddk.nih.gov
3. Endocrine Society Clinical Practice Guideline. “Diagnosis and Treatment of Primary Adrenal Insufficiency.” 2021. https://www.endocrine.org
4. World Health Organization. “Tuberculosis.” 2023. https://www.who.int
5. Cleveland Clinic. “Hyperpigmentation: Causes and Treatments.” 2024. https://my.clevelandclinic.org

```